July 26th, 2011: RecipharmCobra Biologics, the international manufacturer of biopharmaceuticals, announces the appointment of Julian Hanak as Commercial Director. He brings a wealth of industry knowledge and experience having held senior positions in both contract service and biotech product development companies. Julian will join the RecipharmCobra management team to build on the company’s growth in provision of manufacturing services for the biotech and biopharmaceutical industry.
Formerly at Renovo Plc (a biopharmaceutical drug discovery and development company), Julian gained senior management and commercial experience as Senior Vice President of Development. Included in Julian’s key responsibilities was the oversight of CMO’s and direction of CMC activities during drug development. Julian previously worked at RecipharmCobra Biologics’ Keele facility for 11 years progressing from Senior Scientist to Director of Production.
Julian also held positions at the National Institute for Medical Research, Bio Products Laboratory Ltd, and AstraZeneca.
Peter Coleman, CEO at RecipharmCobra Biologics, said: “I am delighted that Julian has decided to join RecipharmCobra Biologics as we look to strengthen our team’s depth of experience to expand our clinical production offering and to reach our goal as a leading commercial supplier for our customers. We all look forward to working with Julian to achieve these goals.”
For media enquiries: please contact Tristan Jervis or Alex Heeley, De Facto Communications on: +44(0) 207 861 3019. E-mail; t.jervis@defacto.com.
